Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Therapeutic Effect of Lifei Xiaoji Wan on Lung Adenocarcinoma in the Early Stage of Ground Glass Nodule (Ia Stage) and Its Effect on Tumor Microenvironment

NCT06387134 is registered in ClinicalTrials.gov with Henan University of Traditional Chinese Medicine as lead sponsor.

NCT NCT06387134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06387134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Therapeutic Effect of Lifei Xiaoji Wan on Lung Adenocarcinoma in the Early Stage of Ground Glass Nodule (Ia Stage) and Its Effect on Tumor Microenvironment
Lead sponsor
Henan University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
May 31, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early stage lung adenocarcinoma